The TNF-related apoptosis-inducing ligand (TRAIL) can trigger apoptosis in many malignant cells [27], but CXCL8 has been shown to block TRAIL-induced cell death by converting a TRAIL-sensitive ovarian cancer cell line (OVCAR3) into a TRAIL-resistant one. Here, CXCL8 is linked to ovarian carcinoma.